TrialPanorama/TrialPanorama-database huggingface dataset:
Study 25710119 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study 25710119 — Predictive Biomarker (PRD): ADRA2A mRNA
Genes: ADRA2A; ADRA2R; ADRAR
Study 12612867 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1376839 — Surrogate Endpoint (SUR): Blood pressure
Study 28793896 — Safety Biomarker (SAF): Interleukin 1
Study 10770538 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9581003 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 11505696 — Surrogate Endpoint (SUR): Blood pressure
Study 31650328 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28905240 — Surrogate Endpoint (SUR): Blood pressure
Study 4603999 — Surrogate Endpoint (SUR): Forced vital capacity
Study 29916784 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 12907528 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 30394916 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25596660 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 1319110 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1319110 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23683448 — Surrogate Endpoint (SUR): Blood pressure
Study 20673739 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study 16505084 — Surrogate Endpoint (SUR): Serum sodium
Study 16505084 — Surrogate Endpoint (SUR): Blood pressure
Study 7691253 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 7691253 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 7691253 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 30318772 — Predictive Biomarker (PRD): FCGR2A mRNA
Genes: FCGR2A; CD32; FCG2; FCGR2A1; IGFR2
Study 30318772 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study 16632346 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 8835126 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 8835126 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22078660 — Surrogate Endpoint (SUR): Bone mineral density
Study 19606508 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15308515 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15308515 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15308515 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 11468195 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 11468195 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 9640412 — Surrogate Endpoint (SUR): Bone mineral density
Study 30650572 — Surrogate Endpoint (SUR): Blood pressure
Study 6355617 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 6355617 — Surrogate Endpoint (SUR): Blood pressure
Study 22749924 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 19470869 — Surrogate Endpoint (SUR): Blood pressure
Study 15671918 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 20938636 — Predictive Biomarker (PRD): TBC1D4 mRNA
Genes: TBC1D4; AS160; KIAA0603
Study 20938636 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 20938636 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 17713471 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 9287260 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 3549320 — Surrogate Endpoint (SUR): Blood pressure
Study 18669951 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10566573 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31260089 — Surrogate Endpoint (SUR): Serum sodium
Study 16385303 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 21825080 — Surrogate Endpoint (SUR): Bone mineral density
Study 21825080 — Surrogate Endpoint (SUR): Serum calcium
Study 19309475 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 19309475 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 7628595 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 28177480 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 28177480 — Surrogate Endpoint (SUR): Pathological complete response
Study 21440864 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 15384821 — Surrogate Endpoint (SUR): Blood pressure
Study 25251749 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 11412051 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8006284 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8006284 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 17079189 — Surrogate Endpoint (SUR): Serum creatinine
Study 17079189 — Surrogate Endpoint (SUR): Blood pressure
Study 9457399 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 29973251 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 29973251 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21083927 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 21083927 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study 1512327 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 30442501 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study 30442501 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 30442501 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 30704923 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 28641384 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 28641384 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Platelet glycoprotein 4
Genes: CD36; GP3B; GP4
Study 24403557 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24403557 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 24403557 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17893256 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 282070 — Surrogate Endpoint (SUR): Blood pressure
Study 7855219 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 7855219 — Surrogate Endpoint (SUR): Blood pressure
Study 28815282 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 28815282 — Surrogate Endpoint (SUR): Serum calcium
Study 9273228 — Surrogate Endpoint (SUR): Blood pressure
Study 1622644 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 31282542 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 31282542 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 31282542 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 31282542 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31282542 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31282542 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 31322200 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 26521589 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 22078337 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 11821289 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11821289 — Safety Biomarker (SAF): Reactive oxygen species
Study 7627386 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7627386 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 28536723 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 18297891 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 8665055 — Surrogate Endpoint (SUR): Forced vital capacity
Study 22803968 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22803968 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 20160062 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 20160062 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 20160062 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 20160062 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 18657891 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 18657891 — Surrogate Endpoint (SUR): Serum calcium
Study 12593498 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 30936281 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24475766 — Surrogate Endpoint (SUR): Blood pressure
Study 22748465 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 22748465 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study 22748465 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 22748465 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 22748465 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study 20495510 — Surrogate Endpoint (SUR): Serum creatinine
Study 18041436 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30298608 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27838831 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27838831 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21849399 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19318111 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 15310772 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 28993177 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study 25547003 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 18268067 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 18268067 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 18268067 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 10362762 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8315433 — Predictive Biomarker (PRD): REM2 mRNA
Genes: REM2
Study 8315433 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 2423798 — Surrogate Endpoint (SUR): Blood pressure
Study 15351856 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 25070091 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 9289710 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 22187234 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17426325 — Predictive Biomarker (PRD): NPY5R mRNA
Genes: NPY5R; NPYR5
Study 17426325 — Surrogate Endpoint (SUR): Blood pressure
Study 30660638 — Predictive Biomarker (PRD): GSTM1 mRNA
Genes: GSTM1; GST1
Study 1376843 — Surrogate Endpoint (SUR): Blood pressure
Study 3884404 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 3884404 — Surrogate Endpoint (SUR): Serum creatinine
Study 19614793 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19614793 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19614793 — Surrogate Endpoint (SUR): Blood pressure
Study 15191590 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 15191590 — Surrogate Endpoint (SUR): Probing pocket depth
Study 23247700 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 23247700 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 20124 — Surrogate Endpoint (SUR): Blood pressure
Study 29275577 — Surrogate Endpoint (SUR): Blood pressure
Study 23885792 — Surrogate Endpoint (SUR): Blood pressure
Study 16835585 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16835585 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15356496 — Surrogate Endpoint (SUR): Bacterial count
Study 11782868 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7700540 — Surrogate Endpoint (SUR): Blood pressure
Study 31471767 — Surrogate Endpoint (SUR): Bone mineral density
Study 7048881 — Surrogate Endpoint (SUR): Blood pressure
Study 18971549 — Surrogate Endpoint (SUR): Blood pressure
Study 18971549 — Surrogate Endpoint (SUR): Serum creatinine
Study 16155076 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 16155076 — Surrogate Endpoint (SUR): Serum testosterone
Study 10849267 — Monitoring Biomarker (MOI): HBV DNA
Study 9089855 — Surrogate Endpoint (SUR): Blood pressure
Study 29970875 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 29970875 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 16540246 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 16540246 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 16540246 — Safety Biomarker (SAF): BDNF
Study 31515837 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study 27901334 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 19843296 — Surrogate Endpoint (SUR): Serum creatinine
Study 18661082 — Surrogate Endpoint (SUR): Blood pressure
Study 8693541 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study 8693541 — Surrogate Endpoint (SUR): Serum creatinine
Study 27210845 — Surrogate Endpoint (SUR): Blood pressure
Study 8524605 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 2255747 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 30169439 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study 29113731 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 23085245 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23085245 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 20220537 — Surrogate Endpoint (SUR): Bone mineral density
Study 20576482 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 20576482 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 31418925 — Surrogate Endpoint (SUR): Blood pressure
Study 26209000 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24635770 — Surrogate Endpoint (SUR): Blood pressure
Study 9591619 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study 9591619 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 25847775 — Surrogate Endpoint (SUR): Blood pressure
Study 25847775 — Surrogate Endpoint (SUR): Serum creatinine
Study 25847775 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19413507 — Surrogate Endpoint (SUR): Blood pressure
Study 21952693 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17431777 — Monitoring Biomarker (MOI): HBV DNA
Study 12358344 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 2262582 — Surrogate Endpoint (SUR): Bacterial count
Study 23615479 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 23615479 — Surrogate Endpoint (SUR): Blood pressure
Study 19158129 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 17410435 — Predictive Biomarker (PRD): GSS mRNA
Genes: GSS
Study 3593994 — Surrogate Endpoint (SUR): Blood pressure
Study 26081100 — Predictive Biomarker (PRD): ABCG1 mRNA
Genes: ABCG1; ABC8; WHT1
Study 19631353 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19631353 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10189118 — Surrogate Endpoint (SUR): Blood pressure
Study 28071011 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 18355402 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study 18355402 — Predictive Biomarker (PRD): Hormone receptor
Study 30343354 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 17686343 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study 9727377 — Surrogate Endpoint (SUR): Serum creatinine
Study 24153053 — Surrogate Endpoint (SUR): Blood pressure
Study 21145258 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 12752845 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 2905992 — Surrogate Endpoint (SUR): Blood pressure
Study 27733377 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25182248 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25182248 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21270200 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 3542445 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 23999037 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23999037 — Surrogate Endpoint (SUR): Blood pressure
Study 26370118 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26370118 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 26370118 — Surrogate Endpoint (SUR): Blood pressure
Study 20538235 — Surrogate Endpoint (SUR): Blood pressure
Study 18165641 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 10509575 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7027708 — Predictive Biomarker (PRD): LYN mRNA
Genes: LYN; JTK8
Study 28950844 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 28950844 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 22328727 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22328727 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 17557981 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 402088 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 15138617 — Safety Biomarker (SAF): MTHFR
Study 12691171 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study 12691171 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 9650545 — Surrogate Endpoint (SUR): Blood pressure
Study 31968595 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31968595 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 22486580 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 1886479 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 6814928 — Surrogate Endpoint (SUR): Blood pressure
Study 24353120 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 17912165 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 27651843 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 21048211 — Surrogate Endpoint (SUR): Blood pressure
Study 1102614 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 19169631 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 17330056 — Surrogate Endpoint (SUR): Blood pressure
Study 9516220 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9516220 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7977117 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7977117 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7977117 — Surrogate Endpoint (SUR): Blood pressure
Study 25655470 — Predictive Biomarker (PRD): PTGDR2 mRNA
Genes: PTGDR2; CRTH2; DL1R; GPR44
Study 10688505 — Surrogate Endpoint (SUR): Blood pressure
Study 10480957 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 7128662 — Surrogate Endpoint (SUR): Serum potassium
Study 7128662 — Surrogate Endpoint (SUR): Blood pressure
Study 29754654 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 11052956 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 1639992 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 6702238 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 30415310 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 27317188 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 11068226 — Surrogate Endpoint (SUR): Blood pressure
Study 24331777 — Surrogate Endpoint (SUR): Blood pressure
Study 20641031 — Surrogate Endpoint (SUR): Serum calcium
Study 20641031 — Surrogate Endpoint (SUR): Bone mineral density
Study 31897748 — Surrogate Endpoint (SUR): Bone mineral density
Study 29066327 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 22751375 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11762412 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31498154 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study 31498154 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 31498154 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study 22613649 — Monitoring Biomarker (MOI): HBV DNA
Study 30789910 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22678104 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD